Overview
Magnapharm Poland develops a portfolio of pharmaceutical brands on the Polish market and supports their presence in Central and Eastern Europe. The company manages the full product lifecycle—from market launch, reimbursement activities and compliance to marketing, sales, logistics and distribution—in areas including allergology, dermatology, ophthalmology, gastroenterology, gynecology, pediatrics and rare diseases.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2005-06-29. Active
66 1050 1025 1000 0023 0374 8319- 80 1050 1038 1000 0022 9289 2573
- 91 1050 1038 1000 0022 9289 2763
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 12,706PLN 12,706 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 27, 2020 | Commercial Companies Code notice | |
| Jun 24, 2014 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
32 tenders recorded as contractor: 3 national ($469,234) and 29 EU ($116,606,701).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 12, 2026 | Zakup i dostawy leków do programów lekowych, cytostatyków oraz leków stosowanych w ramach procedury rdtl | –– | Kliniczny Szpital Wojewódzki Im. Św. Jadwigi Królowej w Rzeszowie | |
| Sep 4, 2026 | Dostawa leków do realizacji programów lekowych | –– | Wojewódzki Szpital Zespolony Im. L. Rydygiera w Toruniu | |
| Aug 27, 2026 | Dostawa leków stosowanych w programach lekowych dla Górnośląskiego Centrum Zdrowia Dziecka im. Św. Jana Pawła II Samodzielnego Publicznego Szpitala Klinicznego nr 6 Śląskiego Uniwersytetu Medycznego w Katowicach 40-752 Katowice ul. Medyków 16 | $3.5M$3,527,527 | Górnośląskie Centrum Zdrowia Dziecka Im. Św. Jana Pawła II Samodzielny Publiczny Szpital Kliniczny Nr 6 Śląskiego Uniwersytetu Medycznego w Katowicach |
Public sector contracts
Magnapharm Poland is the contractor in 19 public sector contracts, worth PLN 31.83m in total. They were signed with 7 public buyers.
| Public buyer | Value | |
|---|---|---|
| Uniwersytecki Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego Pum w Szczecinie | PLN 146,459 | |
| Uniwersytecki Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego Pum w Szczecinie | PLN 188,304 | |
| Uniwersytecki Szpital Kliniczny w Opolu | PLN 627,681 | |
| Uniwersytecki Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego Pum w Szczecinie | PLN 188,304 | |
| Uniwersytecki Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego Pum w Szczecinie | PLN 125,536 |
Trademarks
Magnapharm Poland holds 3 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2020.
| Mark | Protected until | |
|---|---|---|
| Helicobiom(word) | Sep 5, 2035 | |
| NEO-VITAL D+DHA | Nov 5, 2030 | |
| NEO-VITAL D 1000 | Oct 21, 2030 | |
| Helicobiom(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magnapharm Holdings Limited | 1,283,101 | $17,329,835.22 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl | ||
| Stada Pharmsp. z o.o. | $98,071,375.86 | walmark.eu | ||
| Olympus Polskasp. z o.o. | $77,594,927.17 | olympus.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-10-11 | Share capital change (57,155,050.00 PLN → 64,155,050.00 PLN) | |
| 2022-04-04 | Address change (Aleje Jerozolimskie 146 D, 02-305, Warszawa → Ul. Inflancka 4, 00-189, Warszawa) | |
| 2021-04-23 | Share capital change (52,675,050.00 PLN → 57,155,050.00 PLN) | |
| 2020-11-06 | Share capital change (43,875,050.00 PLN → 52,675,050.00 PLN) | |
| 2020-03-31 | Name change ("a&d Pharma Poland" → Magnapharm Poland) |
FAQ
Last updated: 2026-10-07